Literature DB >> 19831872

Taurine reduces inflammatory responses after spinal cord injury.

Yasuhiro Nakajima1, Koji Osuka, Yukio Seki, Ramesh C Gupta, Masahito Hara, Masakazu Takayasu, Toshihiko Wakabayashi.   

Abstract

Taurine has multiple functions in the central nervous system (CNS), serving as an osmoregulator, antioxidant, inhibitory neuromodulator, and regulator of intracellular Ca(2+) flux. Since the role of taurine in traumatic spinal cord injury (SCI) is not fully understood, the present study was conducted with C57 black/6 mice (18-20 g) who underwent severe SCI at the Th-8 level using a weight compression device. Taurine was injected intraperitoneally at doses of 25, 80, 250, and 800 mg/kg within 30 min after SCI. Controls were injected with saline. The contusional cord segments were removed 6 h after SCI, and concentrations of interleukin-6 (IL-6) and myeloperoxidase (MPO) were measured using ELISA kits. Phosphorylation of STAT3, which is activated by IL-6, and expression of inducible cyclooxygenase-2 (COX-2) were also compared between the taurine treatment group (250 mg/kg) and the control group by Western blot analysis. Morphological changes were evaluated with H&E-stained sections. Taurine significantly decreased IL-6 and MPO levels in a dose-dependent manner, significantly reducing the phosphorylation of STAT3 and expression of COX-2 after SCI compared to controls. A reduced accumulation of neutrophils, especially in the subarachnoid spaces, and secondary degenerative changes in gray matter were also noted, and motor disturbances were significantly attenuated with taurine treatment (250 mg/kg). These findings indicate that taurine has anti-inflammatory effects against SCI, and may play a neuroprotective role against secondary damage, and thus it may have therapeutic potential.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19831872     DOI: 10.1089/neu.2009.1044

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  20 in total

1.  Synergistic effect of ascorbic acid and taurine in the treatment of a spinal cord injury-induced model in rats.

Authors:  Chao Chen; Qiang Yang; Xinlong Ma
Journal:  3 Biotech       Date:  2020-01-16       Impact factor: 2.406

Review 2.  Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review).

Authors:  Stella Baliou; Anthony M Kyriakopoulos; Demetrios A Spandidos; Vassilios Zoumpourlis
Journal:  Int J Oncol       Date:  2020-07-14       Impact factor: 5.650

3.  Taurine supplementation reduces myeloperoxidase and matrix-metalloproteinase-9 levels and improves the effects of exercise in cognition and physical fitness in older women.

Authors:  Matheus Uba Chupel; Luciele Guerra Minuzzi; Guilherme Eustáquio Furtado; Mário Leonardo Santos; José Pedro Ferreira; Edith Filaire; Ana Maria Teixeira
Journal:  Amino Acids       Date:  2021-02-13       Impact factor: 3.520

4.  Dietary taurine supplementation attenuates lipopolysaccharide-induced inflammatory responses and oxidative stress of broiler chickens at an early age.

Authors:  Hongli Han; Jingfei Zhang; Yanan Chen; Mingming Shen; Enfa Yan; Chengheng Wei; Caiyun Yu; Lili Zhang; Tian Wang
Journal:  J Anim Sci       Date:  2020-10-01       Impact factor: 3.159

5.  Tempol reduces injury area in rat model of spinal cord contusion injury through suppression of iNOS and COX-2 expression.

Authors:  Hong-Hua Quan; Ku-Seong Kang; Yoon-Kyung Sohn; Ming Li
Journal:  Neurol Sci       Date:  2013-01-25       Impact factor: 3.307

6.  The nephroprotective properties of taurine-amikacin treatment in rats are mediated through HSP25 and TLR-4 regulation.

Authors:  Neveen Madbouly; Ayman Azmy; Abeer Salama; Azza El-Amir
Journal:  J Antibiot (Tokyo)       Date:  2021-07-12       Impact factor: 2.649

7.  A combined treatment of curcumin, piperine, and taurine alters the circulating levels of IL-10 and miR-21 in hepatocellular carcinoma patients: a pilot study.

Authors:  Hala M Hatab; Fatma F Abdel Hamid; Ahmed F Soliman; Tamer A Al-Shafie; Yahia M Ismail; Motawa E El-Houseini
Journal:  J Gastrointest Oncol       Date:  2019-08

8.  A systematic review of preclinical studies on the efficacy of taurine for the treatment of rheumatoid arthritis.

Authors:  Aida Malek Mahdavi; Zeinab Javadivala
Journal:  Amino Acids       Date:  2021-04-30       Impact factor: 3.520

9.  Heteroarylketones inhibit astroglial interleukin-6 expression via a STAT3/NF-κB signaling pathway.

Authors:  Ingo Schulz; Claudia Engel; André J Niestroj; Ulrike Zeitschel; Katja Menge; Astrid Kehlen; Antje Meyer; Steffen Rossner; Hans-Ulrich Demuth
Journal:  J Neuroinflammation       Date:  2011-07-29       Impact factor: 8.322

10.  Anti-interleukin-6 receptor antibody reduces neuropathic pain following spinal cord injury in mice.

Authors:  Tomotoshi Murakami; Tsukasa Kanchiku; Hidenori Suzuki; Yasuaki Imajo; Yuichiro Yoshida; Hiroshi Nomura; Dan Cui; Toshizo Ishikawa; Eiji Ikeda; Toshihiko Taguchi
Journal:  Exp Ther Med       Date:  2013-09-13       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.